Live News Categoriesequity

GenSight Biologics S.A. (SIGHT.PA) News

Track canonical SquawkNews coverage tagged to SIGHT.PA, GenSight Biologics S.A.. This hub brings together deduplicated headlines about paris, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol SIGHT.PA Asset equity Sector Markets 90 days 1 Last 0.1138 Updated Sep 29, 2026, 10:50 PM UTC Open live news feed

M GenSight Biologics (SIGHT.PA) H1 2026 net loss widens to €10.3 mln, going-concern warning GenSight Biologics said its H1 2026 net loss widened to €10.3 mln versus a steady loss per share of €0.05 and warned of material uncertainty over going concern without additional funding. EARNINGS | Sep 29, 2026, 10:50 PM UTC